Cellyan Biotechnology (HKPD) Long-Term Deferred Tax (2024)
Cellyan Biotechnology (HKPD) posted quarterly Long-Term Deferred Tax of $2.2 million for Q3 2024, up 71.54% quarter-over-quarter from $1.3 million in Q1 2024.
Cellyan Biotechnology (HKPD) Long-Term Deferred Tax (2024) Analysis & Trends
Cellyan Biotechnology (HKPD) has reported Long-Term Deferred Tax for 1 consecutive years, with $2.2 million the latest figure, recorded in Q3 2024.
- In Q3 2024, Long-Term Deferred Tax changed N/A year-over-year to $2.2 million; the TTM figure through Sep 2024 stood at $2.2 million (changed N/A YoY), while the FY2024 annual figure was $1.3 million, changed N/A from the prior year.
- Long-Term Deferred Tax advanced to $2.2 million in Q3 2024 per HKPD's latest filing, from $1.3 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $2.2 million in Q3 2024 and bottomed at $1.3 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn |
| 10 | Cellyan Biotechnology | 6.70 Mn | 6.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 2.16 Mn |
| Mar 31, 2024 | 1.26 Mn |